|
SoCalBio Vendor Spotlight
Aubery Group (Irvine)
A SoCalBio Member Since 2004
Led by CEO Mr. Tom Allen, Aubrey Group, Inc. is a contract product development and manufacturing company using state-of-the-art technologies to develop new medical devices and biotech instruments. Our expertise is designing and engineering innovative solutions for clients in the therapeutic, surgical, patient monitoring and diagnostic industries ... Learn more
|
Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in Los Angeles, Orange County and neighboring communities for job creation and overall economic growth.
|  |
| Thanks to SoCalBio Media Partners
|
|
|
|
June 21st, 2013
|  Editor: Ahmed Enany
President & CEO
Southern California
Biomedical Council
enany@socalbio.org
www.socalbio.org
|
|
Genomics
|
Report by Battelle Tracks $965 Billion in Economic Impact from the Genomics Revolution
 Battelle did the report for a group called United for Medical Research, which has a mission of advocating for a bigger investment in the NIH. And Battelle says it could track $965 billion in economic impact from the genomics field--all linked to the thriving life sciences sector that has emerged in the wake of the Human Genome Project. "Between 1988 and 2012, the federal government's $14.5 billion investment in the field of genomics represents an expenditure of only $2 per year per U.S. resident, with an enormous economic and societal impact from that investment," said Martin Grueber, research leader, Battelle and co-author, "The Impact of Genomics on the U.S. Economy" ... Access executive summary
|
|
MARK YOUR CALENDAR
Featuring Next Gen. Medtech, Biotech & eHealth Companies To sponsor or make a business presentation, contact SoCalBio at |
|
Patenting Genes
|
Court Decision on Gene Patents Impacts GM Crops
 Biotechnology companies fear that a recent U.S. Supreme Court decision banning patents on human genes will undermine protections for genetically engineered crops. The nation's highest court has ruled that a naturally occurring sequence of DNA isn't eligible for patent protections, voiding human gene patents held by a medical testing company. The underlying conflict in the case pertained to genes that carry mutations associated with breast and ovarian cancers, but experts say the ruling has implications for agricultural biotechnology and beyond ... Read more
|
| Coming in July |
SoCalBio Workforce Summit & Job Fair
Building the Bioeconomy Talent Pipeline
July 25, 2013, 8 am to 4 pm
East Los Angels Community College, Building G1 Room 301 A & B
1301 Avenida Cesar Chavez, Monterey Park, CA 91754
|
|
Sponsored Events
|
October 8 - 9, 2013 in San Francisco, CA
-------------------------------------------------------------------------------------------------------
November 11 - 13 in Beijing, China
|
|
Neuromodulation
|
The Los Angeles-Based NeuroSigma Announces Debut of Its Monarch eTNS System in Canada
 NeuroSigma, Inc., a Los Angeles based medical device company, announced that its Monarch eTNS System for the adjunctive treatment of epilepsy and depression will make its Canadian debut at the 30th International Epilepsy Congress, taking place in Montreal, Canada from June 23 to June 27, 2013. TheMonarch eTNS System will be on display at the NeuroSigma Booth #413 throughout the conference ... Read more
|
|
Moving in
|
The Los Angeles-Based Response Genetics Appoints Kevin Harris CFO
 Prior to joining Response Genetics, Mr. Harris, 44 years old, served as Chief Financial Officer of CyberDefender Corporation from January 2009 to August 2012 and as Chief Operating Officer of Statmon Technologies Corp from April 2004 to January 2009. Mr. Harris began his career at KPMG Peat Marwick as a senior auditor and his other professional experience includes serving as Head of Production, Finance at PolyGram Television, Director of Corporate Financial Planning at Metro-Goldwyn-Mayer Studios and Senior Vice President of Finance at RKO Pictures. Mr. Harris earned a Bachelor of Science in Business Administration from California State University, San Bernardino and is a Certified Public Accountant in the State of California ... Read more
|
|
Dry Eye Device
|
OASIS Medical Inc. and Shape Ophthalmics, LLC Announce Joint Venture to Introduce an Innovative Shape Memory Polymer Punctal Plug
 The Glendora, CA-based OASIS Medical Inc., manufacturer and distributor of high quality reusable and disposable surgical instruments, punctal occlusion devices, and ocular lubricating and cleansing solutions, is pleased to enter a joint venture with Shape Ophthalmics, LLC, Denver, CO, introducing a proprietary shape memory plug technology triggered by natural body heat. This unique punctal plug for the treatment of dry eye will be manufactured exclusively by OASIS Medical Inc. for worldwide distribution ... Learn more
|
|
Troponin Assay
|
Beckman Coulter Gets FDA Clearance Of New Access AccuTnI+3 Troponin I Assay
 Beckman Coulter, a subsidiary of Danaher Corp., said the U.S. Food and Drug Administration, or FDA, has granted clearance of its new Access AccuTnI+3 troponin I assay for use on its Access 2 immunoassay system. "Clinicians have depended on Beckman Coulter's troponin I test for over 12 years and the new AccuTnI+3 assay has the proven performance to continue providing dependability to laboratories supporting emergency care," said Arnd Kaldowski, president, Beckman Coulter Diagnostics ... Read more
|
|
New Funding
| |
The Irvine-Based Vertos Medical Raises $23M
in Series E Round
 Pitango Venture Capital, a new investor, led the round while Vertos' existing investors - ONSET Ventures, CHL Medical Partners, Foundation Medical Partners, Mercury Fund and Aweida Venture Partners - also participated. Earlier this year, the company raised $1.8 million, according to a regulatory filing ... Read more
Cataract surgery devices maker WaveTec raises $11 million of a hoped-for $18 million
 The Aliso Viejo-based WaveTec is developing its ORA System, a diagnostic device that provide continuous measurements of a patient's eye during cataract surgery, allowing for more precise measurements to help improve refractive outcomes ... Read more
|
|
Product Recall
| |
Gilead Recalls 20 Batches of AmBisome Due to Possible Contamination in its San Dimas Plant
Gilead Sciences has recalled bateches of its antifungal drug AmBisome after bacterial contamination was discovered during a routine test at its plant in San Dimas, CA. This plant was the subject of a 2010 FDA warning letter in which inspectors took the company to task for some of the processes and controls in its aseptic filling area ... Read more
|
| Join SoCalBio | |
Become a SoCalBio Member and Save Money by Utlizing the SoCalBio Group Purchasing Program
|
| Jobs Available |
Aubrey Group (Irvine)
ChromoLogic (Pasadena)
Second Sight Medical Products (Sylmar) Alfred Mann Foundation for Scientific Research (Santa Clarita) C/A ARCHITECTS (Los Beach) - Director of Infrastructure (The company is looking for a director who has an architectural or engineering background. Send resumes to: Brent Oswald)
WaveTec Vision (Aliso Viejo) Response Genetics (Los Angeles) Tribogenics (Marina del Rey)
Click to access more info
BioLase (Irvine) STAAR Surgical (Monrovia) ImaginAB (Inglewood) Absorption Systems (San Diego) Replenish Inc. (Pasadena) Click here for more info and to apply - Electrical Engineer (REQ #:12-04)
- Facilities Maintenance Worker (REQ #:12-29)
- Process Engineer/MEMS Fabrication (REQ #:12-31)
- Process Development Engineer (REQ #:12-32)
- Process Development Engineer (REQ #:12-33)
Puma Biotechnology (Los Angeles)
Bioject (Orange County)
Helix Medical (Baldwin Park)
|
|
| About SoCalBio |
 SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
